AMANTA Q2 : NET PROFIT UP 302% AT ₹4.86 CR (YOY)

• Revenue up 17.3% at ₹83.13 Cr (YOY); H1FY27 revenue up 11.6% at ₹151.94 Cr. • EBITDA up 21.9% at ₹17.95 Cr (YOY), includes other income; margins 21.6% vs 20.8% (YOY), up ~80 bps. • PAT up 302% at ₹4.86 Cr (YOY); H1FY27 PAT up 12% at ₹8.17 Cr, margin 5.85% vs 1.70% (YOY). • SteriPort Line 3 commissioned in September 2026, lifting capacity 75% to 11.6 crore bottles; seen adding ~₹60 Cr revenue in FY27. • SVP capacity expansion to 31.7 crore units targeted Q1FY28; 10.8 MW captive solar seen saving ~₹9 Cr annually. • Caution: Q2FY26 PAT base was after a ₹2.63 Cr exceptional item; PBT before exceptionals up 39% at ₹6.83 Cr. Impact: Strong PAT growth on low base; capacity expansion and solar savings support FY27 outlook.

Amanta Healthcare Ltd

Open attachment

← Back to feed